Sigyn Therapeutics (SIGY) Finished Goods (2017 - 2020)

Sigyn Therapeutics has disclosed Finished Goods across 4 years of filings, most recently posting $134145.0 for Q3 2020.

• In Q3 2020, Finished Goods changed 0.0% year-over-year to $134145.0; the TTM figure through Sep 2020 stood at $134145.0 (changed 0.0% YoY), while the FY2019 annual figure was $134145.0, changed 0.0% from the prior year.
• Finished Goods came in at $134145.0 for Q3 2020 at Sigyn Therapeutics, roughly flat from $134145.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $134145.0 in Q4 2017 to a low of $134145.0 in Q4 2017.
• Average Finished Goods over 4 years is $134145.0, with a median of $134145.0 recorded in 2017.
• The largest YoY upside for Finished Goods was 0.0% in 2018 against a maximum downside of 0.0% in 2018.
• Over 4 years, Finished Goods stood at $134145.0 in 2017, then changed by 0.0% to $134145.0 in 2018, then changed by 0.0% to $134145.0 in 2019, then changed by 0.0% to $134145.0 in 2020.
• Per Business Quant data, the three most recent Finished Goods figures were $134145.0 in Q3 2020, $134145.0 in Q2 2020, and $134145.0 in Q1 2020.